Fukuoka S, Hara H, Takahashi N, Kojima T, et al. Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603). J Clin Oncol 2020 Apr 28:JCO1903296. doi: 10.1200/JCO.19.03296.
PMID: 32343640